Katherine A High insider trades

Open-market stock purchases and sales by Katherine A High, Director at Incyte Corp, from SEC Form 4 filings since Feb 4, 2015.

Recent trades

DateStockTradeValue
Jun 8, 2026INCY Incyte CorpBought (not open market)—
Jun 8, 2026INCY Incyte CorpBought (not open market)—
Jun 5, 2026CRSP CRISPR Therapeutics AGBought (not open market)—

Companies traded

  • INCY Incyte Corp: other filings, last Jun 8, 2026
  • CRSP CRISPR Therapeutics AG: other filings, last Jun 5, 2026
  • ONCE Spark Therapeutics, Inc: 1 buy, 35 sales, last Dec 17, 2019

Get free alerts when Katherine A High files a new trade →